Arthur T. Sands
2014 - Lexicon Pharmaceuticals
In 2014, Arthur T. Sands earned a total compensation of $1M as Former President, Chief Executive Officer and Director at Lexicon Pharmaceuticals, a 42% decrease compared to previous year.
Compensation breakdown
| Salary | $301,154 |
|---|---|
| Other | $717,324 |
| Total | $1,018,478 |
Sands received $717.3K in other compensation, accounting for 70% of the total pay in 2014.
Sands also received $301.2K in salary.
Rankings
In 2014, Arthur T. Sands' compensation ranked 7,523rd out of 13,032 executives tracked by ExecPay. In other words, Sands earned more than 42.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,523 out of 13,032 | 42nd |
Division Manufacturing | 2,779 out of 4,965 | 44th |
Major group Chemicals And Allied Products | 941 out of 1,690 | 44th |
Industry group Drugs | 740 out of 1,369 | 46th |
Industry Pharmaceutical Preparations | 572 out of 1,042 | 45th |
Source: SEC filing on March 13, 2015.
Sands' colleagues
We found five more compensation records of executives who worked with Arthur T. Sands at Lexicon Pharmaceuticals in 2014.
2014
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
2014
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2014
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
2014
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
2014
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, CMC and Supply Operations
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021